Multiple giant cell lesions in a patient with Noonan syndrome with multiple lentigines.

作者: Henk van den Berg , Willem Hans Schreuder , Marjolijn Jongmans , Danielle van Bommel-Slee , Bart Witsenburg

DOI: 10.1016/J.EJMG.2016.05.013

关键词:

摘要: A patient with Noonan syndrome multiple lentigines (NSML) and giant cell lesions (MGCL) in mandibles maxillae is described. mutation p.Thr468Met the PTPN11-gene was found. This second reported NSML MGCL. Our case adds to assumption that, despite a different molecular pathogenesis effect on RAS/MEK pathway, shares development of MGCL, other RASopathies.

参考文章(42)
Marco Tartaglia, Ernest L. Mehler, Rosalie Goldberg, Giuseppe Zampino, Han G. Brunner, Hannie Kremer, Ineke van der Burgt, Andrew H. Crosby, Andra Ion, Steve Jeffery, Kamini Kalidas, Michael A. Patton, Raju S. Kucherlapati, Bruce D. Gelb, Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics. ,vol. 29, pp. 465- 468 ,(2001) , 10.1038/NG772
L Folgueira, A Algeciras, W S MacMorran, G D Bren, C V Paya, The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B. Journal of Virology. ,vol. 70, pp. 2332- 2338 ,(1996) , 10.1128/JVI.70.4.2332-2338.1996
Yasuyoshi Ueki, Valdenize Tiziani, Carla Santanna, Naomi Fukai, Chris Maulik, Judah Garfinkle, Chisho Ninomiya, Cassio doAmaral, Hartmut Peters, Mutaz Habal, Laila Rhee-Morris, Jeffrey B. Doss, Sven Kreiborg, Bjorn R. Olsen, Ernst Reichenberger, Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nature Genetics. ,vol. 28, pp. 125- 126 ,(2001) , 10.1038/88832
Mylène Tajan, Audrey de Rocca Serra, Philippe Valet, Thomas Edouard, Armelle Yart, SHP2 sails from physiology to pathology. European Journal of Medical Genetics. ,vol. 58, pp. 509- 525 ,(2015) , 10.1016/J.EJMG.2015.08.005
M. Harris, Central giant cell granulomas of the jaws regress with calcitonin therapy British Journal of Oral & Maxillofacial Surgery. ,vol. 31, pp. 89- 94 ,(1993) , 10.1016/0266-4356(93)90168-V
Yoko Aoki, Tetsuya Niihori, Yoko Narumi, Shigeo Kure, Yoichi Matsubara, None, The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Human Mutation. ,vol. 29, pp. 992- 1006 ,(2008) , 10.1002/HUMU.20748
Cory M Resnick, Jeffrey Margolis, Srinivas M Susarla, Joseph H Schwab, Francis J Hornicek, Thomas B Dodson, Leonard B Kaban, None, Maxillofacial and Axial/Appendicular Giant Cell Lesions: Unique Tumors or Variants of the Same Disease?—A Comparison of Phenotypic, Clinical, and Radiographic Characteristics Journal of Oral and Maxillofacial Surgery. ,vol. 68, pp. 130- 137 ,(2010) , 10.1016/J.JOMS.2009.04.106
M. Michael Cohen, Robert J. Gorlin, Noonan-like/multiple giant cell lesion syndrome. American Journal of Medical Genetics. ,vol. 40, pp. 159- 166 ,(1991) , 10.1002/AJMG.1320400208
Alessandra Fragale, Marco Tartaglia, Jie Wu, Bruce D. Gelb, Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Human Mutation. ,vol. 23, pp. 267- 277 ,(2004) , 10.1002/HUMU.20005
Jan de Lange, Hans P. van den Akker, Henk van den Berg, Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. ,vol. 104, pp. 603- 615 ,(2007) , 10.1016/J.TRIPLEO.2007.04.003